Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
Jiahao Li, Yingnan Liu, Ruipeng Zheng, et al.
Life Sciences (2024) Vol. 342, pp. 122540-122540
Open Access | Times Cited: 9

Showing 9 citing articles:

Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization
Xiaoliu Liang, Hui Liu, Hu Chen, et al.
Aggregate (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 18
Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
Qinxue Sun, Zi Liang Wu, Xi Yin, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Molecular subtyping combined with multiomics analysis to study correlation between TACE refractoriness and tumor stemness in hepatocellular carcinoma
Qifan He, Yue Xiong, Xiaoyu Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Targeting Glycolytic Enzymes with 3-Bromopyruvic Acid to Enhance the Efficacy of Interventional Embolization in Hepatocellular Carcinoma
Min Wang, Xiaoning Wu, Xu Cheng, et al.
Current Medical Science (2025)
Closed Access
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Sheng Zhong, Fengtao Zhang, Haiming Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 445-458
Closed Access
The role of TACE in the era of immune-targeted therapy for hepatocellular carcinoma: a meta-analysis based on PSM
Jiahao Li, Lei Xian, Xinsen Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Endoplasmic Reticulum Membrane Protein Complex Regulates Cancer Stem Cells and is Associated with Sorafenib Resistance in Hepatocellular Carcinoma
Yuan-jie Liu, Jing-Xiao Li, Jie-pin Li, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1519-1539
Open Access | Times Cited: 1
Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Application of nanotechnology in the treatment of hepatocellular carcinoma
Liu Cai, Yanyuan Du, Hongtai Xiong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization
Weilang Wang, Shuhang Zhang, Bin‐Yan Zhong, et al.
Abdominal Radiology (2024)
Closed Access
Page 1

Scroll to top